サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1753307

塞栓防止ストッキングの世界市場

Anti-Embolism Stockings

出版日
ページ情報
英文 364 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
塞栓防止ストッキングの世界市場
出版日: 2025年06月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 364 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

塞栓防止ストッキングの世界市場は2030年までに9億7,380万米ドルに達する見込み

2024年に7億7,070万米ドルと推定される塞栓防止ストッキングの世界市場は、2030年には9億7,380万米ドルに達し、分析期間2024-2030年のCAGRは4.0%で成長すると予測されます。ふくらはぎ丈塞栓防止ストッキングは、本レポートで分析したセグメントの1つであり、CAGRは4.8%を記録し、分析期間終了時には6億1,420万米ドルに達すると予測されています。Thigh-Lengthの塞栓防止ストッキングセグメントの成長率は、分析期間中CAGR 2.7%と推定されます。

米国市場は2億1,000万米ドル、中国はCAGR 7.5％で成長予測

米国の塞栓防止ストッキング市場は、2024年に2億1,000万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 7.5%で推移し、2030年には1億9,940万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.6%と3.1%と予測されています。欧州では、ドイツがCAGR 2.3%で成長すると予測されています。

世界の塞栓防止ストッキング市場- 主要動向と促進要因のまとめ

塞栓防止ストッキングが術後や寝たきりの患者ケアに欠かせない要素になりつつある理由とは？

塞栓防止ストッキングは、静脈血栓塞栓症（VTE）予防の重要なツールとして、特に手術中や寝たきりの患者向けに登場しました。下肢を段階的に圧迫するように設計されたこの特殊なストッキングは、静脈血を心臓に押し戻すことで血液循環を促進し、血栓形成の主な原因となるうっ血を防ぐ。このストッキングの役割は、大手術や外傷、長期の療養などで動けないことが、深部静脈血栓症（DVT）や肺塞栓症（PE）のリスクを著しく高める病院環境において、特に重要となっています。各分野のヘルスケアプロバイダーは現在、塞栓防止ストッキングをリスクのある患者に対する標準治療と考えており、合併症を減らすために抗凝固療法と併用することが多いです。術後患者、特に整形外科、腹部、心臓血管系の手術から回復した患者は、数日から数週間にわたって動きが制限される可能性があるため、塞栓防止ストッキングの使用は非常に有益です。さらに、集中治療室（ICU）、老人病棟、リハビリテーションセンターの患者にも広く推奨されています。病院が患者の転帰や安全性を重視するようになるにつれ、DVTのような院内感染の発生率を下げることが最優先事項となり、塞栓防止ストッキングが広く使用されるようになりました。塞栓防止ストッキングの費用対効果、使いやすさ、非侵襲的な性質は、入院患者や外来患者の両方にとって魅力的な選択肢となっています。多くの場合、これらのストッキングの使用は医療機関のプロトコルや医療保険プロバイダーによって義務付けられており、現代の予防医学におけるその役割はさらに確固たるものとなっています。

塞栓防止ストッキングの有効性を高めている医療および素材のイノベーションとは？

医療用繊維と圧迫技術における最近の進歩は、塞栓防止ストッキングの快適性、有効性、コンプライアンスを著しく向上させています。歴史的には、不快感、不適切なサイズ、ストッキングを着用することの難しさなどが患者の服用を制限していました。今日のストッキングは、通気性、低刺激性、抗菌性の素材で作られており、皮膚への刺激を軽減し、衛生面を損なうことなく長時間の着用を可能にしています。段階的着圧技術も進化しており、通常足首で最も高く、大腿部に向かって徐々に低くなる着圧レベルを正確にコントロールすることで、動きを制限したり組織に損傷を与えたりすることなく、静脈還流を最適化することができます。シームレスな編み方と人間工学に基づいたデザインにより、解剖学的なフィット感が向上し、治療効果が高まるだけでなく、使用者の快適性も向上しています。現在では、体温調節が可能なスマートファイバーを組み込んだストッキングもあり、これは気候の異なる場所での長期着用に特に有益です。さらに、色分けされたサイジング・システムや伸縮性の向上により、製品選択が簡素化され、不適切な使用によるリスクが減少しています。3Dボディースキャナーやモバイルアプリなどのデジタルツールは、特に外来患者における正確なフィッティングを支援するために使用されています。一方、静脈圧や動きをリアルタイムでモニターできるセンサー内蔵ストッキングの研究も進められており、これらの衣服が診断ツールにもなる可能性があります。このような技術革新は、塞栓防止ストッキングの臨床的・機能的水準を高め、患者の服薬アドヒアランスの向上、転帰の改善を確実にし、より広範な医療シナリオへの応用を広げています。

世界の人口動向とヘルスケアは、塞栓防止ストッキング市場をどのように拡大していますか？

塞栓防止ストッキングの世界市場は、マクロレベルでの人口動態の変化と進化するヘルスケア提供モデルによって形成されています。特に北米、欧州、アジアの一部の地域では、加齢に伴う静脈不全、運動制限、外科的介入の有病率が著しく高くなっています。高齢者はVTEに罹患しやすく、日常診療の一環として塞栓防止ストッキングのような予防策が処方されることが多くなっています。さらに、肥満、心血管疾患、糖尿病などの慢性疾患の負担が増加しているため、血栓のリスクがさらに高まり、積極的な介入が必要となっています。同時に、選択的手術、特に人工膝関節置換術や人工股関節置換術などの整形外科的手術の頻度が増加しているため、入院中と退院後の両方の環境において、これらの製品に対する安定した需要が生じています。外来手術や当日退院モデルへのシフトにより、患者管理型の予防ケアの必要性が高まっており、塞栓防止ストッキングはこれらのプロトコルで中心的な役割を果たしています。新興国市場もまた、ヘルスケアのインフラが整備され、VTE予防に対する意識が高まるにつれて市場開拓に貢献しています。公衆衛生キャンペーンや施設の義務化により、特に外科手術や長期療養環境におけるDVT予防の重要性が高まっています。また、保険償還や包括的治療の取り組みにより、費用対効果の高い非薬理学的予防法の使用がさらに奨励されています。これと並行して、オンライン小売チャネルやe-pharmaciesは、在宅医療ソリューションを求める消費者がストッキングをより入手しやすくし、臨床環境以外での使用を後押ししています。このような人口動態と構造的な変化が相まって、様々な医療レベルにおいて塞栓防止ストッキングに対する持続的な世界的需要が生まれています。

世界中で塞栓防止ストッキングの採用が増加している主な要因は何ですか？

塞栓防止ストッキング市場の成長は、臨床需要、ヘルスケア政策、技術改善、消費者行動に根ざしたいくつかの説得力のある要因によってもたらされています。最も重要な要因の一つは、特に入院患者、術後患者、動けない患者におけるVTEの発生率の増加です。規制機関や専門の医師会は、標準的な予防法として圧迫療法の使用を推奨するガイドラインを発行しており、このカテゴリーは医学的に正当であり、制度的にも支持されています。エビデンスに基づく医療の採用により、病院は合併症、再入院、関連するヘルスケアコストの削減を目指し、手術の回復プロトコルに塞栓防止ストッキングを広く取り入れるようになりました。もう一つの大きな推進力は、繊維工学の継続的な進歩であり、これによってメーカーは、より効果的なだけでなく、より着用しやすいストッキングを製造できるようになり、患者のコンプライアンスと満足度の向上につながりました。遠隔医療や遠隔患者管理の人気が高まっていることも寄与しており、臨床医は特に整形外科手術や心臓血管手術の後、自宅で療養している患者に圧迫着を勧めています。さらに、健康意識の高まりと積極的な健康行動により、消費者は直接処方箋がなくても、圧迫ストッキングのような予防医療製品に投資するようになっています。流通は劇的に拡大し、現在では薬局、オンライン・プラットフォーム、医療供給業者、さらには健康関連小売業者を通じて製品が入手できるようになっています。ヘルスケア・プロバイダーとメーカー間の戦略的パートナーシップや、患者と臨床医の双方を対象とした教育イニシアティブが、採用をさらに後押ししています。これらの要因は、早期介入、予防医療、非侵襲的な治療オプションの重視と相まって、塞栓防止ストッキングの役割を世界中の現代ヘルスケアシステムの基本的な要素として確固たるものにしています。

セグメント

製品（ふくらはぎ丈の塞栓防止ストッキング,太もも丈の塞栓防止ストッキング）;人口統計（男性,女性）;エンドユース（外来患者エンドユース,術後患者エンドユース,妊婦エンドユース,その他エンドユース）

調査対象企業の例（計 34社）

  • 3M Company
  • B. Braun Melsungen AG
  • BSN Medical GmbH
  • Cardinal Health Inc.
  • Covidien（Medtronic）
  • Essity AB
  • Halyard Health Inc.
  • Kendall（Covidien）
  • Lohmann & Rauscher GmbH
  • Medline Industries, Inc.
  • Molnlycke Health Care AB
  • Paul Hartmann AG
  • Prestige Brands Holdings Inc.
  • Sanko Medical Co., Ltd.
  • Sigvaris AG
  • Smith & Nephew plc
  • Solidea S.r.l.
  • Thermo Fisher Scientific Inc.
  • Thuasne Group
  • Unomedical（a part of Coloplast）

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオトランスクリプト、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中のドメインエキスパートからキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36174

Global Anti-Embolism Stockings Market to Reach US$973.8 Million by 2030

The global market for Anti-Embolism Stockings estimated at US$770.7 Million in the year 2024, is expected to reach US$973.8 Million by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Calf-Length Anti-Embolism Stockings, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$614.2 Million by the end of the analysis period. Growth in the Thigh-Length Anti-Embolism Stockings segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$210.0 Million While China is Forecast to Grow at 7.5% CAGR

The Anti-Embolism Stockings market in the U.S. is estimated at US$210.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$199.4 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Anti-Embolism Stockings Market - Key Trends & Drivers Summarized

Why Are Anti-Embolism Stockings Becoming a Critical Component of Post-Surgical and Bedridden Patient Care?

Anti-embolism stockings have emerged as a crucial tool in the prevention of venous thromboembolism (VTE), particularly for patients undergoing surgery or confined to bed rest. Designed to apply graduated pressure to the lower limbs, these specialized stockings enhance blood circulation by pushing venous blood back toward the heart, thereby preventing stasis-a key contributor to clot formation. Their role has become especially vital in hospital environments where immobility, whether due to major surgery, trauma, or prolonged recovery, significantly elevates the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). Healthcare providers across disciplines now consider anti-embolism stockings a standard of care for at-risk patients, often using them in combination with anticoagulant therapies to reduce complications. Postoperative patients, especially those recovering from orthopedic, abdominal, or cardiovascular procedures, benefit enormously from their use, as movement may be restricted for days or even weeks. Moreover, they are widely recommended for patients in intensive care units (ICUs), geriatric wards, and rehabilitation centers. As hospitals increasingly focus on patient outcomes and safety metrics, reducing the incidence of hospital-acquired conditions like DVT has become a top priority-thus driving the widespread use of anti-embolism stockings. Their cost-effectiveness, ease of application, and non-invasive nature make them an attractive option for both inpatient and outpatient settings. In many cases, the use of these stockings is mandated by institutional protocols and health insurance providers, further cementing their role in modern preventive medicine.

What Medical and Material Innovations Are Enhancing the Efficacy of Anti-Embolism Stockings?

Recent advances in medical textiles and compression technology are significantly improving the comfort, effectiveness, and compliance associated with anti-embolism stockings. Historically, patient adherence was limited due to discomfort, improper sizing, or difficulty in donning the stockings-issues that have now been addressed through more sophisticated designs and materials. Today’s stockings are made with breathable, hypoallergenic, and antimicrobial fabrics that reduce skin irritation and allow for prolonged wear without compromising hygiene. Graduated compression technology has also evolved, allowing for precise control over pressure levels-typically highest at the ankle and gradually decreasing toward the thigh-to optimize venous return without constricting movement or causing tissue damage. Seamless knitting techniques and ergonomic designs ensure a better anatomical fit, which not only improves therapeutic outcomes but also enhances user comfort. Some stockings now incorporate smart fibers capable of temperature regulation, which is particularly beneficial for long-term wear in varied climates. In addition, color-coded sizing systems and improved elasticity have simplified product selection and reduced the risk of improper usage. Digital tools such as 3D body scanners and mobile apps are being used to assist with accurate fitting, especially in outpatient scenarios. Meanwhile, research is ongoing into sensor-embedded stockings that can monitor venous pressure or movement in real-time, potentially transforming these garments into diagnostic tools as well. These technological innovations are raising the clinical and functional standards of anti-embolism stockings, ensuring better patient adherence, improved outcomes, and expanding their application across a wider spectrum of medical scenarios.

How Are Global Demographic Trends and Healthcare Practices Expanding the Market for Anti-Embolism Stockings?

The global market for anti-embolism stockings is being shaped by macro-level demographic shifts and evolving healthcare delivery models. A key factor is the aging global population, particularly in regions like North America, Europe, and parts of Asia, where the prevalence of age-related venous insufficiency, limited mobility, and surgical interventions is significantly higher. Older adults are more susceptible to VTE, and preventive measures like anti-embolism stockings are increasingly prescribed as part of routine care. Additionally, the growing burden of chronic diseases such as obesity, cardiovascular conditions, and diabetes further increases the risk of blood clots, necessitating proactive interventions. At the same time, the rising frequency of elective surgeries-particularly orthopedic procedures such as knee and hip replacements-has created a steady demand for these products in both hospital and post-discharge settings. The shift toward outpatient surgery and same-day discharge models has heightened the need for patient-managed preventive care, with anti-embolism stockings playing a central role in these protocols. Developing nations are also contributing to market growth as healthcare infrastructure improves and awareness of VTE prevention increases. Public health campaigns and institutional mandates are reinforcing the importance of DVT prophylaxis, especially in surgical and long-term care environments. Insurance reimbursement and bundled care initiatives are further incentivizing the use of cost-effective, non-pharmacological preventive measures. In parallel, online retail channels and e-pharmacies are making these stockings more accessible to consumers seeking at-home medical solutions, supporting their use beyond the clinical setting. Collectively, these demographic and structural shifts are creating sustained, global demand for anti-embolism stockings across multiple levels of care.

What Are the Core Drivers Behind the Rising Adoption of Anti-Embolism Stockings Worldwide?

The growth in the anti-embolism stockings market is driven by several compelling factors grounded in clinical demand, healthcare policy, technological improvement, and consumer behavior. One of the most critical drivers is the increasing incidence of VTE, particularly among hospitalized, post-surgical, and immobile patients-a demographic that continues to expand with rising hospitalization rates and longer life expectancy. Regulatory agencies and professional medical associations have issued guidelines recommending the use of compression therapy as a standard preventive measure, giving the category both medical legitimacy and institutional support. The adoption of evidence-based medicine has led to widespread incorporation of anti-embolism stockings in surgical recovery protocols, with hospitals aiming to reduce complications, readmissions, and associated healthcare costs. Another major driver is the continuous advancement in textile engineering, allowing manufacturers to create stockings that are not only more effective but also more wearable-leading to better patient compliance and satisfaction. The increasing popularity of telehealth and remote patient management is also contributing, as clinicians recommend compression wear for patients recovering at home, especially after orthopedic or cardiovascular procedures. Moreover, the rise in health awareness and proactive wellness behaviors has encouraged consumers to invest in preventive health products like compression stockings even without a direct prescription. Distribution has expanded dramatically, with products now available via pharmacies, online platforms, medical suppliers, and even wellness retailers. Strategic partnerships between healthcare providers and manufacturers, along with educational initiatives aimed at both patients and clinicians, are further driving adoption. These factors-combined with a focus on early intervention, preventive care, and non-invasive treatment options-are cementing the role of anti-embolism stockings as a fundamental component of modern healthcare systems around the world.

SCOPE OF STUDY:

The report analyzes the Anti-Embolism Stockings market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Calf-Length Anti-Embolism Stockings, Thigh-Length Anti-Embolism Stockings); Demography (Men, Women); End-Use (Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • 3M Company
  • B. Braun Melsungen AG
  • BSN Medical GmbH
  • Cardinal Health Inc.
  • Covidien (Medtronic)
  • Essity AB
  • Halyard Health Inc.
  • Kendall (Covidien)
  • Lohmann & Rauscher GmbH
  • Medline Industries, Inc.
  • Molnlycke Health Care AB
  • Paul Hartmann AG
  • Prestige Brands Holdings Inc.
  • Sanko Medical Co., Ltd.
  • Sigvaris AG
  • Smith & Nephew plc
  • Solidea S.r.l.
  • Thermo Fisher Scientific Inc.
  • Thuasne Group
  • Unomedical (a part of Coloplast)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Anti-Embolism Stockings - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Surgical and Postoperative Complication Awareness Throws the Spotlight on Anti-Embolism Stockings
    • Use in DVT Prevention Among Hospitalized and Immobile Patients Drives Demand
    • OEMs Offering Graduated Compression Stockings With Improved Comfort Enhance Wearability
    • Expansion of Preventive Protocols in Orthopedic, Cardiac, and Cancer Surgeries Spurs Market Uptake
    • Rising Elderly and Postpartum Populations Support Broad-Based Prophylactic Use
    • OEMs Emphasizing Latex-Free, Breathable, and Skin-Friendly Fabrics Improve Patient Compliance
    • Growth in Long-Distance Travel and Air Travel Health Awareness Supports Consumer-Grade Adoption
    • Integration With Smart Monitoring Wearables for Circulation Adds Technological Edge
    • Use in Homecare and Outpatient Recovery Strengthens Demand for Over-the-Counter Stockings
    • OEMs Offering Size-Variant and Adjustable Designs Enhance Personalization and Fit
    • Increased Emphasis on Fall Prevention and Mobility Support Expands Multifunctional Use
    • Growing Institutional Adoption in ICU and Rehabilitation Centers Drives Bulk Procurement
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Anti-Embolism Stockings Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Calf-Length Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Calf-Length Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Calf-Length Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Thigh-Length Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Thigh-Length Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Thigh-Length Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Men by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Men by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Men by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Women by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Women by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Women by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Ambulatory Patients End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Post-operative Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Post-operative Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Post-operative Patients End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pregnant Women End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pregnant Women End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Pregnant Women End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Anti-Embolism Stockings by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: France 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: France 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Anti-Embolism Stockings by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: India 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: India 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: India 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Anti-Embolism Stockings by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Anti-Embolism Stockings by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION